IL12RB2 is a subunit of the IL-12 receptor, and an increased ratio of IL12RB2-positive tumor-infiltrating lymphocytes is indicative of a good prognosis in laryngeal cancer [32]. This evidence concerns the gene IL12RB2 and neoplasm.